4.8 Article

Caspase-11 Controls Interleukin-1β Release through Degradation of TRPC1

Journal

CELL REPORTS
Volume 6, Issue 6, Pages 1122-1128

Publisher

CELL PRESS
DOI: 10.1016/j.celrep.2014.02.015

Keywords

-

Categories

Funding

  1. National Institute on Aging [R37 AG012859]
  2. French National Research Agency [ANR-13-JSV3-0002-01]
  3. European Research Council [ERC-2012-StG_20111109]
  4. Agence Nationale de la Recherche (ANR) [ANR-13-JSV3-0002] Funding Source: Agence Nationale de la Recherche (ANR)

Ask authors/readers for more resources

Caspase-11 is a highly inducible caspase that controls both inflammatory responses and cell death. Caspase-11 controls interleukin 1 beta (IL-1 beta) secretion by potentiating caspase-1 activation and induces caspase-1-independent pyroptosis downstream of noncanonical NLRP3 inflammasome activators such as lipopolysaccharide (LPS) and Gram-negative bacteria. However, we still know very little about the downstream mechanism of caspase-11 in regulating inflammation because the known substrates of caspase-11 are only other caspases. Here, we identify the cationic channel subunit transient receptor potential channel 1 (TRPC1) as a substrate of caspase-11. TRPC1 deficiency increases the secretion of IL-1 beta without modulating caspase-1 cleavage or cell death in cultured macrophages. Consistently, trpc1(-/-) mice show higher IL-1 beta secretion in the sepsis model of intraperitoneal LPS injection. Altogether, our data suggest that caspase-11 modulates the cationic channel composition of the cell and thus regulates the unconventional secretion pathway in a manner independent of caspase-1.

Authors

I am an author on this paper
Click your name to claim this paper and add it to your profile.

Reviews

Primary Rating

4.8
Not enough ratings

Secondary Ratings

Novelty
-
Significance
-
Scientific rigor
-
Rate this paper

Recommended

No Data Available
No Data Available